Sign up to receive exclusive communications about offerings, events, news, surveys, special offers, and related topics via telephone, email and other forms of electronic communications.
In 2015, the European Commission classified imidazole as a CMR substance and added H360D statement (“may damage the unborn child”). So far, alternatives to imidazole have adversely impacted the performance of Karl Fischer reagents and users have had limited options to move away from any potential CMR risk. Now, after dedicated research, the Hydranal Center of Excellence has developed new reagents that are free of imidazole and do not compromise on performance.Read The European Commission Report
Some more content here
NOTE: There is no need to develop new analysis methods when upgrading to Hydranal FI reagents. An official statement can be found here.